$IDAI
T Stamp Inc Stock $idai

$idai Overview Financials Valuation SEC Filings Company Website

2024 Q4 Form 10-Q Financial Statement

#000171893924000202 Filed on November 15, 2024

Income Statement

Concept	2024 Q4	2024 Q3
Revenue		$511.1K
YoY Change		-83.33%
Cost Of Revenue		$254.9K
YoY Change		6.2%
Gross Profit		$256.2K
YoY Change		-90.95%
Gross Profit Margin		50.13%
Selling, General & Admin		$2.182M
YoY Change		6.25%
% of Gross Profit		851.68%
Research & Development		$569.5K
YoY Change		-5.9%
% of Gross Profit		222.3%
Depreciation & Amortization		$8.000K
YoY Change		-20.0%
% of Gross Profit		3.12%
Operating Expenses		$3.188M
YoY Change		3.24%
Operating Profit		-$2.677M
YoY Change		12131.29%
Interest Expense		-$114.3K
YoY Change		1043.2%
% of Operating Profit
Other Income/Expense, Net		$3.360M
YoY Change		-25406.67%
Pretax Income		$683.5K
YoY Change		-2043.92%
Income Tax		$0.00
% Of Pretax Income		0.0%
Net Earnings		-$1.256M
YoY Change		3471.8%
Net Earnings / Revenue		-245.74%
Basic Earnings Per Share		-$0.07
Diluted Earnings Per Share		-$0.07
COMMON SHARES
Basic Shares Outstanding	23.15M shares	16.78M shares
Diluted Shares Outstanding		17.72M shares

Balance Sheet

Concept	2024 Q4	2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments		$598.0K
YoY Change		-81.19%
Cash & Equivalents		$598.0K
Short-Term Investments
Other Short-Term Assets		$281.4K
YoY Change		-19.59%
Inventory
Prepaid Expenses		$254.0K
Receivables		$375.7K
Other Receivables		$23.78K
Total Short-Term Assets		$2.211M
YoY Change		-48.57%
LONG-TERM ASSETS
Property, Plant & Equipment		$39.83K
YoY Change		-34.23%
Goodwill		$1.249M
YoY Change		0.0%
Intangibles		$193.3K
YoY Change		-9.96%
Long-Term Investments		$5.100M
YoY Change
Other Assets		$35.38K
YoY Change		57.17%
Total Long-Term Assets		$8.348M
YoY Change		163.11%
TOTAL ASSETS
Total Short-Term Assets		$2.211M
Total Long-Term Assets		$8.348M
Total Assets		$10.56M
YoY Change		41.31%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable		$1.107M
YoY Change		61.23%
Accrued Expenses		$1.670M
YoY Change		93.9%
Deferred Revenue		$95.75K
YoY Change		9.46%
Short-Term Debt		$0.00
YoY Change
Long-Term Debt Due		$645.5K
YoY Change		303.46%
Total Short-Term Liabilities		$3.662M
YoY Change		78.68%
LONG-TERM LIABILITIES
Long-Term Debt		$1.007M
YoY Change		11.44%
Other Long-Term Liabilities		$321.3K
YoY Change		10.78%
Total Long-Term Liabilities		$1.007M
YoY Change		11.44%
TOTAL LIABILITIES
Total Short-Term Liabilities		$3.662M
Total Long-Term Liabilities		$1.007M
Total Liabilities		$4.991M
YoY Change		53.88%
SHAREHOLDERS EQUITY
Retained Earnings		-$55.45M
YoY Change		25.88%
Common Stock		$188.2K
YoY Change		128.27%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity		$5.407M
YoY Change
Total Liabilities & Shareholders Equity		$10.56M
YoY Change		41.31%

Cashflow Statement

Concept	2024 Q4	2024 Q3
OPERATING ACTIVITIES
Net Income		-$1.256M
YoY Change		3471.8%
Depreciation, Depletion And Amortization		$8.000K
YoY Change		-20.0%
Cash From Operating Activities		-$2.426M
YoY Change		5.49%
INVESTING ACTIVITIES
Capital Expenditures		$223.6K
YoY Change		31.54%
Acquisitions
YoY Change
Other Investing Activities		-$100.0K
YoY Change
Cash From Investing Activities		-$323.6K
YoY Change		102.26%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		2.741M
YoY Change		349.41%
NET CHANGE
Cash From Operating Activities		-2.426M
Cash From Investing Activities		-323.6K
Cash From Financing Activities		2.741M
Net Change In Cash		-8.420K
YoY Change		-99.54%
FREE CASH FLOW
Cash From Operating Activities		-$2.426M
Capital Expenditures		$223.6K
Free Cash Flow		-$2.650M
YoY Change		7.28%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	598031	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3140747	usd
CY2024Q3	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	4463	usd
CY2023Q4	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	143219	usd
CY2024Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	375732	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	686327	usd
CY2024Q3	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	23781	usd
CY2023Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	44087	usd
CY2024Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1213924	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	826781	usd
CY2024Q3	us-gaap	Assets Current AssetsCurrent	2211468	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	4697942	usd
CY2024Q3	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	1532357	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	223690	usd
CY2024Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	39825	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	56436	usd
CY2024Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	198634	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	164740	usd
CY2024Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	86436	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	139670	usd
CY2024Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-55446691	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-50853285	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	5407302	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	3753441	usd
CY2024Q3	us-gaap	Minority Interest MinorityInterest	161439	usd
CY2023Q4	us-gaap	Minority Interest MinorityInterest	161439	usd
CY2024Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	5568741	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3914880	usd
CY2024Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	10559627	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	7893314	usd
CY2024Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	511081	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3065804	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1585153	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3985242	usd
CY2024Q3	idai	Cost Of Goods And Services Excluding Depreciation Depletion And Amortization CostOfGoodsAndServicesExcludingDepreciationDepletionAndAmortization	254892	usd
CY2023Q3	idai	Cost Of Goods And Services Excluding Depreciation Depletion And Amortization CostOfGoodsAndServicesExcludingDepreciationDepletionAndAmortization	239313	usd
	idai	Cost Of Goods And Services Excluding Depreciation Depletion And Amortization CostOfGoodsAndServicesExcludingDepreciationDepletionAndAmortization	796925	usd
	idai	Cost Of Goods And Services Excluding Depreciation Depletion And Amortization CostOfGoodsAndServicesExcludingDepreciationDepletionAndAmortization	660199	usd
CY2024Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	569506	usd
CY2023Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	605196	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1586085	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1811962	usd
CY2023Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2053524	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	6805995	usd
CY2024Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	181472	usd
CY2023Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	189655	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	547467	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	596109	usd
CY2024Q3	us-gaap	Operating Expenses OperatingExpenses	3187777	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	3087688	usd
	us-gaap	Operating Expenses OperatingExpenses	9736472	usd
	us-gaap	Operating Expenses OperatingExpenses	8968985	usd
CY2024Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-2676696	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-21884	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-8151319	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-4983743	usd
CY2024Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-974	usd
CY2023Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	2142	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-5842	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-3473	usd
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.49
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.71
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	13368169	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	13368169	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6658205	shares
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	625144	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	6.27
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P1Y11M12D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	usd
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	3825	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.57
CY2024Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2024Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	4.21
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	395983	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	6.24
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P1Y8M19D
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	5900715	usd
	dei	Security12b Title Security12bTitle	Class A Common Stock, $0.01 par value per share
	dei	Trading Symbol TradingSymbol	IDAI
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
CY2024Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	23145179	shares
CY2024Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	35375	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	29468	usd
CY2023Q4	us-gaap	Assets Assets	7893314	usd
CY2024Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	1107276	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1232118	usd
CY2024Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	48235	usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	82101	usd
CY2024Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1670260	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1143890	usd
CY2024Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	95750	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	10800	usd
CY2024Q3	us-gaap	Taxes Payable Current TaxesPayableCurrent	0	usd
CY2023Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	1975	usd
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Period End Date DocumentPeriodEndDate	2024-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity Registrant Name EntityRegistrantName	T Stamp Inc
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	81-3777260
	dei	Entity Address City Or Town EntityAddressCityOrTown	Atlanta
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	30305
	dei	Local Phone Number LocalPhoneNumber	806-9906
CY2023Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	1472374	usd
CY2024Q3	us-gaap	Goodwill Goodwill	1248664	usd
CY2023Q4	us-gaap	Goodwill Goodwill	1248664	usd
CY2024Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	193304	usd
CY2024Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.07
CY2024Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.07
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	17717247	shares
CY2024Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	17717247	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	8155617	shares
CY2024Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	351593	usd
CY2024Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-88623	usd
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	2000	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	7464312	usd
	idai	Reverse Stock Split Rounding ReverseStockSplitRounding	0	usd
	idai	Stockholder S Equity Repayment Of Shareholders Loan Through In Kind Services StockholderSEquityRepaymentOfShareholdersLoanThroughInKindServices	18547	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	305350	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-30842	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3914880	usd
	dei	Entity Central Index Key EntityCentralIndexKey	0001718939
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	us-gaap	Impairment Of Intangible Asset Finite Lived Statement Of Income Or Comprehensive Income Extensible Enumeration ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration	http://fasb.org/us-gaap/2024#ResearchAndDevelopmentExpense
	us-gaap	Impairment Of Intangible Asset Finite Lived Statement Of Income Or Comprehensive Income Extensible Enumeration ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration	http://fasb.org/us-gaap/2024#ResearchAndDevelopmentExpense
CY2023Q1	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	0.2
	us-gaap	Impairment Of Intangible Asset Finite Lived Statement Of Income Or Comprehensive Income Extensible Enumeration ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration	http://fasb.org/us-gaap/2024#ResearchAndDevelopmentExpense
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Entity Address Address Line1 EntityAddressAddressLine1	3017 Bolling Way NE, Floor 2
	dei	Entity Address State Or Province EntityAddressStateOrProvince	GA
	dei	City Area Code CityAreaCode	404
CY2024Q3	us-gaap	Long Term Investments LongTermInvestments	5100000	usd
CY2023Q4	us-gaap	Long Term Investments LongTermInvestments	0	usd
CY2024Q3	us-gaap	Assets Assets	10559627	usd
CY2024Q3	us-gaap	Loans Payable Current LoansPayableCurrent	645536	usd
CY2023Q4	us-gaap	Loans Payable Current LoansPayableCurrent	0	usd
CY2024Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	95367	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	81236	usd
CY2024Q3	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	0	usd
CY2023Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	162130	usd
CY2024Q3	us-gaap	Liabilities Current LiabilitiesCurrent	3662424	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2714250	usd
CY2024Q3	us-gaap	Shares Subject To Mandatory Redemption Settlement Terms Fair Value Of Shares SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares	250694	usd
CY2023Q4	us-gaap	Shares Subject To Mandatory Redemption Settlement Terms Fair Value Of Shares SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares	256536	usd
CY2024Q3	us-gaap	Interest Receivable Noncurrent InterestReceivableNoncurrent	45383	usd
CY2023Q4	us-gaap	Interest Receivable Noncurrent InterestReceivableNoncurrent	40317	usd
CY2024Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1007213	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	953877	usd
CY2024Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	70555	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	53771	usd
CY2024Q3	us-gaap	Liabilities Liabilities	4990886	usd
CY2023Q4	us-gaap	Liabilities Liabilities	3978434	usd
CY2024Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2024Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2024Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2024Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	18819750	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	9198089	shares
CY2024Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	18819750	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	9143355	shares
CY2024Q3	us-gaap	Common Stock Value CommonStockValue	188198	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	91434	usd
CY2024Q3	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	0	shares
CY2023Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	54734	shares
CY2024Q3	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	0	usd
CY2023Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	0	usd
CY2024Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	60579359	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	54375622	usd
CY2024Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2181907	usd
CY2024Q3	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-114320	usd
CY2023Q3	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-9759	usd
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-149644	usd
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-29753	usd
CY2024Q3	idai	Others Non Operating Income OthersNonOperatingIncome	5000563	usd
CY2023Q3	idai	Others Non Operating Income OthersNonOperatingIncome	0	usd
	idai	Others Non Operating Income OthersNonOperatingIncome	5235417	usd
	idai	Others Non Operating Income OthersNonOperatingIncome	261217	usd
CY2024Q3	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	1526997	usd
CY2023Q3	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	1377	usd
	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	1533702	usd
	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	4174	usd
CY2024Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	3360220	usd
CY2023Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-13278	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	3557913	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	230763	usd
CY2024Q3	idai	Net Income Loss Including Portion Attributable To Noncontrolling Interest Excluding Dividend Adjustments NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestExcludingDividendAdjustments	683524	usd
CY2023Q3	idai	Net Income Loss Including Portion Attributable To Noncontrolling Interest Excluding Dividend Adjustments NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestExcludingDividendAdjustments	-35162	usd
	idai	Net Income Loss Including Portion Attributable To Noncontrolling Interest Excluding Dividend Adjustments NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestExcludingDividendAdjustments	-4593406	usd
	idai	Net Income Loss Including Portion Attributable To Noncontrolling Interest Excluding Dividend Adjustments NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestExcludingDividendAdjustments	-4752980	usd
CY2024Q3	idai	Dividend Income Deemed Dividends DividendIncomeDeemedDividends	1939439	usd
CY2023Q3	idai	Dividend Income Deemed Dividends DividendIncomeDeemedDividends	0	usd
	idai	Dividend Income Deemed Dividends DividendIncomeDeemedDividends	1939439	usd
	idai	Dividend Income Deemed Dividends DividendIncomeDeemedDividends	0	usd
CY2024Q3	us-gaap	Profit Loss ProfitLoss	-1255915	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	-35162	usd
	us-gaap	Profit Loss ProfitLoss	-6532845	usd
	us-gaap	Profit Loss ProfitLoss	-4752980	usd
CY2024Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	usd
CY2023Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-1255915	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-35162	usd
	us-gaap	Net Income Loss NetIncomeLoss	-6532845	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4752980	usd
CY2024Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.07
CY2024Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.07
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.49
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.71
CY2024Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	17717247	shares
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	17717247	shares
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	8155617	shares
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	8155617	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	8155617	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6658205	shares
CY2024Q3	us-gaap	Profit Loss ProfitLoss	-1255915	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	-35162	usd
	us-gaap	Profit Loss ProfitLoss	-6532845	usd
	us-gaap	Profit Loss ProfitLoss	-4752980	usd
CY2024Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-88623	usd
CY2023Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	18204	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-53234	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-30842	usd
CY2024Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-88623	usd
CY2023Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	18204	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-53234	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-30842	usd
CY2024Q3	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-1344538	usd
CY2023Q3	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-16958	usd
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-6586079	usd
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-4783822	usd
CY2024Q3	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	0	usd
CY2023Q3	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	0	usd
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	0	usd
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	0	usd
CY2024Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1344538	usd
CY2023Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-16958	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-6586079	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-4783822	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3479200	usd
CY2023Q3	idai	Exercise Of Warrants To Common Stock ExerciseOfWarrantsToCommonStock	621000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	-1853	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	148040	usd
CY2023Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	18204	usd
CY2023Q3	idai	Net Income Loss Including Portion Attributable To Noncontrolling Interest Excluding Dividend Adjustments NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestExcludingDividendAdjustments	-35162	usd
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	4229429	usd
CY2024Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	911837	usd
CY2024Q3	idai	Exercise Of Prefunded Warrants To Common Stock ExerciseOfPrefundedWarrantsToCommonStock	0	usd
CY2024Q3	idai	Exercise Of Warrants To Common Stock ExerciseOfWarrantsToCommonStock	3477787	usd
CY2024Q3	idai	Adjustments To Additional Paid In Capital Termination Of Warrants AdjustmentsToAdditionalPaidInCapitalTerminationOfWarrants	483560	usd
CY2024Q3	us-gaap	Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings	1939439	usd
CY2024Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	2655622	usd
CY2024Q3	idai	Net Income Loss Including Portion Attributable To Noncontrolling Interest Excluding Dividend Adjustments NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestExcludingDividendAdjustments	683524	usd
CY2024Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	5568741	usd
	idai	Exercise Of Warrants To Common Stock ExerciseOfWarrantsToCommonStock	622554	usd
	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	-24656	usd
	idai	Net Income Loss Including Portion Attributable To Noncontrolling Interest Excluding Dividend Adjustments NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestExcludingDividendAdjustments	-4752980	usd
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	4229429	usd
	idai	Exercise Of Prefunded Warrants To Common Stock ExerciseOfPrefundedWarrantsToCommonStock	0	usd
	idai	Exercise Of Warrants To Common Stock ExerciseOfWarrantsToCommonStock	3477787	usd
	idai	Adjustments To Additional Paid In Capital Termination Of Warrants AdjustmentsToAdditionalPaidInCapitalTerminationOfWarrants	483560	usd
	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	-56992	usd
	us-gaap	Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings	1939439	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	4346102	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	956603	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-53234	usd
	idai	Net Income Loss Including Portion Attributable To Noncontrolling Interest Excluding Dividend Adjustments NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestExcludingDividendAdjustments	-4593406	usd
CY2024Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	5568741	usd
	idai	Net Income Loss Including Portion Attributable To Noncontrolling Interest Excluding Dividend Adjustments NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestExcludingDividendAdjustments	-4593406	usd
	idai	Net Income Loss Including Portion Attributable To Noncontrolling Interest Excluding Dividend Adjustments NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestExcludingDividendAdjustments	-4752980	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	547467	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	596109	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	956603	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	305350	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-5842	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-3473	usd
	idai	Repayment Of Shareholders Loan Through In Kind Services RepaymentOfShareholdersLoanThroughInKindServices	0	usd
	idai	Repayment Of Shareholders Loan Through In Kind Services RepaymentOfShareholdersLoanThroughInKindServices	18547	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	23595	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	16819	usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	216189	usd
	us-gaap	Paid In Kind Interest PaidInKindInterest	133146	usd
	us-gaap	Paid In Kind Interest PaidInKindInterest	28958	usd
	idai	Non Cash Lease Expense NonCashLeaseExpense	109700	usd
	idai	Non Cash Lease Expense NonCashLeaseExpense	151001	usd
	idai	Non Cash Write Off NonCashWriteOff	-162130	usd
	idai	Non Cash Write Off NonCashWriteOff	-15775	usd
	us-gaap	Gain Loss On Disposition Of Intangible Assets GainLossOnDispositionOfIntangibleAssets	-3751	usd
	us-gaap	Gain Loss On Disposition Of Intangible Assets GainLossOnDispositionOfIntangibleAssets	-17589	usd
	idai	Loss On Inducement Agreements LossOnInducementAgreements	-360307	usd
	idai	Loss On Inducement Agreements LossOnInducementAgreements	0	usd
	idai	Gain Loss On Termination Of Warrant Agreement GainLossOnTerminationOfWarrantAgreement	-1166440	usd
	idai	Gain Loss On Termination Of Warrant Agreement GainLossOnTerminationOfWarrantAgreement	0	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	5000000	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	0	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-310595	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-467129	usd
	us-gaap	Increase Decrease In Due From Related Parties Current IncreaseDecreaseInDueFromRelatedPartiesCurrent	-20306	usd
	us-gaap	Increase Decrease In Due From Related Parties Current IncreaseDecreaseInDueFromRelatedPartiesCurrent	-396	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	387143	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-40220	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	5907	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	20442	usd
	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-124842	usd
	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-258376	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	526370	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-238431	usd
	us-gaap	Increase Decrease In Due To Related Parties Current IncreaseDecreaseInDueToRelatedPartiesCurrent	-33866	usd
	us-gaap	Increase Decrease In Due To Related Parties Current IncreaseDecreaseInDueToRelatedPartiesCurrent	-145274	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	84950	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-1724202	usd
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-1975	usd
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-5616	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-111277	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-145483	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-6183158	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5884123	usd
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	usd
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	377360	usd
	idai	Increase Decrease In Investments IncreaseDecreaseInInvestments	-100000	usd
	idai	Increase Decrease In Investments IncreaseDecreaseInInvestments	0	usd
	us-gaap	Payments For Software PaymentsForSoftware	502206	usd
	us-gaap	Payments For Software PaymentsForSoftware	478338	usd
	idai	Payments For Patent Application Costs PaymentsForPatentApplicationCosts	71883	usd
	idai	Payments For Patent Application Costs PaymentsForPatentApplicationCosts	78169	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	12617	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	538	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-686706	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-179685	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	3985795	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	7464312	usd
	idai	Payments From Termination Of Warrants PaymentsFromTerminationOfWarrants	1650000	usd
	idai	Payments From Termination Of Warrants PaymentsFromTerminationOfWarrants	0	usd
	us-gaap	Payment Of Financing And Stock Issuance Costs PaymentOfFinancingAndStockIssuanceCosts	56992	usd
	us-gaap	Payment Of Financing And Stock Issuance Costs PaymentOfFinancingAndStockIssuanceCosts	24656	usd
	idai	Proceeds From Exercise Of Warrants To Common Stock ProceedsFromExerciseOfWarrantsToCommonStock	1538348	usd
	idai	Proceeds From Exercise Of Warrants To Common Stock ProceedsFromExerciseOfWarrantsToCommonStock	622554	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	2000	usd
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	845000	usd
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	0	usd
	us-gaap	Repayments Of Debt RepaymentsOfDebt	287228	usd
	us-gaap	Repayments Of Debt RepaymentsOfDebt	0	usd
	idai	Principal Payment On Derivatives PrincipalPaymentOnDerivatives	0	usd
	idai	Principal Payment On Derivatives PrincipalPaymentOnDerivatives	29715	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	4374923	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	8034495	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-47775	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-42678	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2542716	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1928009	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3140747	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1254494	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	598031	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3182503	usd
	us-gaap	Interest Paid Net InterestPaidNet	2356	usd
	us-gaap	Interest Paid Net InterestPaidNet	580	usd
	idai	Non Cash Activity Of Warrants Received In Lieu Of Cash NonCashActivityOfWarrantsReceivedInLieuOfCash	5000000	usd
	idai	Non Cash Activity Of Warrants Received In Lieu Of Cash NonCashActivityOfWarrantsReceivedInLieuOfCash	0	usd
	idai	Adjustment To Operating Lease Right Of Use Assets Related To Renewed Leases AdjustmentToOperatingLeaseRightOfUseAssetsRelatedToRenewedLeases	143594	usd
	idai	Adjustment To Operating Lease Right Of Use Assets Related To Renewed Leases AdjustmentToOperatingLeaseRightOfUseAssetsRelatedToRenewedLeases	82185	usd
	idai	Adjustment To Operating Lease Operating Lease Liabilities Related To Renewed Leases AdjustmentToOperatingLeaseOperatingLeaseLiabilitiesRelatedToRenewedLeases	142192	usd
	idai	Adjustment To Operating Lease Operating Lease Liabilities Related To Renewed Leases AdjustmentToOperatingLeaseOperatingLeaseLiabilitiesRelatedToRenewedLeases	83298	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	82095	usd
	idai	Non Cash Activity Of Operating Lease Liabilities Related To Terminated Leases NonCashActivityOfOperatingLeaseLiabilitiesRelatedToTerminatedLeases	0	usd
	idai	Non Cash Activity Of Operating Lease Liabilities Related To Terminated Leases NonCashActivityOfOperatingLeaseLiabilitiesRelatedToTerminatedLeases	77648	usd
	idai	Non Cash Activity Of Prepaid Rent Expense Reclassified Upon Termination Of Leases NonCashActivityOfPrepaidRentExpenseReclassifiedUponTerminationOfLeases	0	usd
	idai	Non Cash Activity Of Prepaid Rent Expense Reclassified Upon Termination Of Leases NonCashActivityOfPrepaidRentExpenseReclassifiedUponTerminationOfLeases	5335	usd
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2024Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
	idai	Net Income Loss Including Portion Attributable To Noncontrolling Interest Excluding Dividend Adjustments NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestExcludingDividendAdjustments	-4590000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-6180000	usd
CY2024Q3	idai	Working Capital In Business WorkingCapitalInBusiness	-1450000	usd
CY2024Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-55450000	usd
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="margin-top:12pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Major Customers and Concentration of Risks —</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of Cash and cash equivalents, and Accounts receivable. We maintain our Cash and cash equivalents with high-quality financial institutions, mainly in the United States; the composition of which are regularly monitored by us. The Federal Deposit Insurance Corporation covers </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$250,000</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for substantially all depository accounts. The Company from time to time may have amounts on deposit in excess of the insured limits. As of September 30, 2024 the Company had </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$30,342 of </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">deposits in excess of insured limits, meanwhile as at December 31, 2023, the Company had $2,620,765 in U.S. bank accounts which exceeded insured limits. Management believes minimal credit risk exists with respect to these financial institutions and the Company has not experienced any losses on such amounts.</span></div><div style="margin-top:12pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For Accounts receivable, we are exposed to credit risk in the event of nonpayment by customers to the extent the amounts are recorded in the consolidated balance sheets. We extend different levels of credit and maintain reserves for potential credit losses based upon the expected collectability of Accounts receivable. We manage credit risk related to our customers by performing periodic evaluations of credit worthiness and applying other credit risk monitoring procedures.</span></div><div style="margin-top:12pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Three customers represented </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">86.87%</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> or 65.12%, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17.12%, and 4.63%</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the balance of total Accounts receivable as of September 30, 2024 and three customers represented 91.11% or 53.55%, 30.43%, and 7.13% of the balance of total Accounts receivable as of December 31, 2023. The Company seeks to mitigate its credit risk with respect to Accounts receivable by contracting with large commercial customers and government agencies, and regularly monitoring the aging of Accounts receivable balances. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2024 and December 31, 2023</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company had not experienced any significant losses on its Accounts receivable.</span></div><div style="margin-top:12pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended September 30, 2024, the Company sold to primarily three customers which made up approximately 93.24% of total Net revenue, and consisted of 66.34%, 17.60%, and 9.30% from an S&P 500 Bank, Mastercard, and Triton, respectively.</span></div><div style="margin-top:12pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, during the three months ended September 30, 2023, the Company sold to primarily three customers which made up approximately 95.85% of total Net revenue, and consisted of 81.87%, 7.91%, and 6.07% from IGS, Mastercard, and an S&P 500 Bank, respectively.</span></div><div style="margin-top:12pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September 30, 2024, the Company sold to primarily three customers which made up approximately 94.68% of total Net revenue, and consisted of 63.66%, 21.07%, and 9.95% from an S&P 500 Bank, Mastercard, and Triton, respectively.</span></div><div style="margin-top:12pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, during the nine months ended September 30, 2023, the Company sold to primarily three customers which made up approximately 90.53% of total Net revenue, and consisted of 62.98%, 14.95%, and 12.60% from IGS, an S&P 500 Bank, and Mastercard, respectively.</span></div>
	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	24000	usd
CY2023	us-gaap	Capitalized Computer Software Impairments1 CapitalizedComputerSoftwareImpairments1	19000	usd
CY2023	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	12000	usd
CY2024Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	511081	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3065804	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1585153	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3985242	usd
CY2020Q2	idai	Minimum Variable Rate For Interest Calculation MinimumVariableRateForInterestCalculation	0.01
CY2020Q2	us-gaap	Short Term Debt Percentage Bearing Fixed Interest Rate ShortTermDebtPercentageBearingFixedInterestRate	0.01
CY2024Q3	idai	Class Of Warrant Or Right Consideration Transferred ClassOfWarrantOrRightConsiderationTransferred	1000000.00	usd
	idai	Percentage Of Discount Of Future Issuance Of Preferred Stock PercentageOfDiscountOfFutureIssuanceOfPreferredStock	0.20
CY2024Q3	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	250000	usd
CY2024Q3	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	250000	usd
CY2016Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	50000	usd
CY2020Q2	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	6418	shares
	idai	Fair Value Adjustment Of Warrants Rounded FairValueAdjustmentOfWarrantsRounded	-6000	usd
CY2024Q3	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	21291406	shares
CY2023Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	6446199	shares
CY2023Q2	idai	Stock Issued During Period Shares Exercise Of Warrants StockIssuedDuringPeriodSharesExerciseOfWarrants	1279700	shares
CY2023Q4	idai	Stock Issued During Period Shares Exercise Of Warrants StockIssuedDuringPeriodSharesExerciseOfWarrants	1573330	shares
CY2024Q3	idai	Payments For Share Subscriptions PaymentsForShareSubscriptions	100000	usd
CY2024Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	253973	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	216875	usd
CY2024Q3	us-gaap	Prepaid Rent PrepaidRent	27458	usd
CY2023Q4	us-gaap	Prepaid Rent PrepaidRent	28400	usd
CY2024Q3	us-gaap	Value Added Tax Receivable ValueAddedTaxReceivable	48177	usd
CY2023Q4	us-gaap	Value Added Tax Receivable ValueAddedTaxReceivable	116095	usd
CY2024Q3	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	25045	usd
CY2023Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	102151	usd
CY2024Q3	us-gaap	Other Assets Miscellaneous Current OtherAssetsMiscellaneousCurrent	859271	usd
CY2023Q4	us-gaap	Other Assets Miscellaneous Current OtherAssetsMiscellaneousCurrent	363260	usd
CY2024Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1213924	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	826781	usd
	idai	Capitalized Computer Software Useful Life CapitalizedComputerSoftwareUsefulLife	P5Y
CY2024Q3	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	4363338	usd
CY2023Q4	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	3901801	usd
CY2024Q3	us-gaap	Capitalized Computer Software Accumulated Amortization CapitalizedComputerSoftwareAccumulatedAmortization	2830981	usd
CY2023Q4	us-gaap	Capitalized Computer Software Accumulated Amortization CapitalizedComputerSoftwareAccumulatedAmortization	2429427	usd
CY2024Q3	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	1532357	usd
CY2023Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	1472374	usd
CY2024Q3	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	141000	usd
CY2023Q3	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	140000	usd
	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	419000	usd
	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	419000	usd
	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	24000	usd
CY2024Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	188856	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	180066	usd
CY2024Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	149031	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	123630	usd
CY2024Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	39825	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	56436	usd
CY2024Q3	us-gaap	Depreciation Depreciation	8000	usd
CY2023Q3	us-gaap	Depreciation Depreciation	10000	usd
	us-gaap	Depreciation Depreciation	27000	usd
	us-gaap	Depreciation Depreciation	62000	usd
CY2024Q3	idai	Compensation Payable CompensationPayable	672587	usd
CY2023Q4	idai	Compensation Payable CompensationPayable	377403	usd
CY2024Q3	us-gaap	Accrued Sales Commission Current AccruedSalesCommissionCurrent	19885	usd
CY2023Q4	us-gaap	Accrued Sales Commission Current AccruedSalesCommissionCurrent	26863	usd
CY2024Q3	idai	Accrued Employee Taxes AccruedEmployeeTaxes	890411	usd
CY2023Q4	idai	Accrued Employee Taxes AccruedEmployeeTaxes	624525	usd
CY2024Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	87377	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	115099	usd
CY2024Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1670260	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1143890	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	626951	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	554481	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	433647	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	330791	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	193304	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	223690	usd
	idai	Number Of Finite Lived Intangible Assets NumberOfFiniteLivedIntangibleAssets	23	patent
CY2024Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	32000	usd
CY2023Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	40000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	102000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	115000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	31949	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	99005	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	52529	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	9821	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	193304	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-1255915	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-35162	usd
	us-gaap	Profit Loss ProfitLoss	-6532845	usd
	us-gaap	Profit Loss ProfitLoss	-4752980	usd
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	17717247	shares
CY2024Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	17717247	shares
CY2024Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	17717247	shares
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	17717247	shares
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	8155617	shares
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	8155617	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	8155617	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	8155617	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	13368169	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	13368169	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6658205	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6658205	shares
CY2024Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.07
CY2024Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.07
CY2024Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.07
CY2024Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.07
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.49
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.49
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.71
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.71
	us-gaap	Dilutive Securities DilutiveSecurities	28576121	usd
	us-gaap	Dilutive Securities DilutiveSecurities	5319603	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	387109	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	6.40
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P1Y5M12D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	11890	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	2.28
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	1230	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	3.25
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	4186	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	5.73
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	393583	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	1425	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	4375	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.37
CY2024Q2	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	510	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	3.92
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	399848	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	6.19
CY2024Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P1Y5M26D
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	usd
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	6550	shares
CY2024Q3	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.92
CY2024Q3	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2024Q3	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	1530	shares
CY2024Q3	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	3.92
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	404868	shares
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	6.11
CY2024Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P1Y3M7D
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	393583	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	6.27
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P1Y11M12D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	14750	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.22
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	3465	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	4.02
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	404868	shares
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	6.11
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P1Y3M7D
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	usd
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	404868	shares
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	6.11
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P1Y3M7D
CY2024Q3	idai	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Exercisable Intrinsic Value1 ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExercisableIntrinsicValue1	0	usd
CY2024Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	0	usd
CY2023Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	0	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.29
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.25
CY2024Q3	idai	Share Based Compensation Arrangement Weighted Average Grant Date Fair Value Of Options Granted Amount ShareBasedCompensationArrangementWeightedAverageGrantDateFairValueOfOptionsGrantedAmount	4000	usd
CY2023Q3	idai	Share Based Compensation Arrangement Weighted Average Grant Date Fair Value Of Options Granted Amount ShareBasedCompensationArrangementWeightedAverageGrantDateFairValueOfOptionsGrantedAmount	10000	usd
CY2024Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	351593	usd
CY2023Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	148040	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	956603	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	305350	usd
CY2024Q3	idai	Minimum Lease Commitments MinimumLeaseCommitments	0	usd
CY2024Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y10M17D
CY2024Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.050
	idai	Number Of Leases Terminated NumberOfLeasesTerminated	1	lease
CY2024Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	198634	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	164740	usd
CY2024Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	95367	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	81236	usd
CY2024Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	70555	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	53771	usd
CY2024Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	165922	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	135007	usd
CY2024Q3	idai	Lessee Operating Lease Liability To Be Paid Net Of Undiscounted Excess Amount Year One LesseeOperatingLeaseLiabilityToBePaidNetOfUndiscountedExcessAmountYearOne	36976	usd
CY2024Q3	idai	Lessee Operating Lease Liability Undiscounted Excess Amount Year One LesseeOperatingLeaseLiabilityUndiscountedExcessAmountYearOne	1921	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	38897	usd
CY2024Q3	idai	Lessee Operating Lease Liability To Be Paid Net Of Undiscounted Excess Amount Year Two LesseeOperatingLeaseLiabilityToBePaidNetOfUndiscountedExcessAmountYearTwo	88889	usd
CY2024Q3	idai	Lessee Operating Lease Liability Undiscounted Excess Amount Year Two LesseeOperatingLeaseLiabilityUndiscountedExcessAmountYearTwo	3696	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	92585	usd
CY2024Q3	idai	Lessee Operating Lease Liability To Be Paid Net Of Undiscounted Excess Amount Year Three LesseeOperatingLeaseLiabilityToBePaidNetOfUndiscountedExcessAmountYearThree	22735	usd
CY2024Q3	idai	Lessee Operating Lease Liability Undiscounted Excess Amount Year Three LesseeOperatingLeaseLiabilityUndiscountedExcessAmountYearThree	1170	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	23905	usd
CY2024Q3	idai	Lessee Operating Lease Liability To Be Paid Net Of Undiscounted Excess Amount Year Four LesseeOperatingLeaseLiabilityToBePaidNetOfUndiscountedExcessAmountYearFour	8831	usd
CY2024Q3	idai	Lessee Operating Lease Liability Undiscounted Excess Amount Year Four LesseeOperatingLeaseLiabilityUndiscountedExcessAmountYearFour	626	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	9457	usd
CY2024Q3	idai	Lessee Operating Lease Liability To Be Paid Net Of Undiscounted Excess Amount After Year Four LesseeOperatingLeaseLiabilityToBePaidNetOfUndiscountedExcessAmountAfterYearFour	8491	usd
CY2024Q3	idai	Lessee Operating Lease Liability Undiscounted Excess Amount After Year Four LesseeOperatingLeaseLiabilityUndiscountedExcessAmountAfterYearFour	178	usd
CY2024Q3	idai	Lessee Operating Lease Liability To Be Paid After Year Four LesseeOperatingLeaseLiabilityToBePaidAfterYearFour	8669	usd
CY2024Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	165922	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	7591	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	173513	usd
CY2024Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	39368	usd
CY2023Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	40060	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	117221	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	169496	usd
CY2024Q3	us-gaap	Short Term Lease Cost ShortTermLeaseCost	10710	usd
CY2023Q3	us-gaap	Short Term Lease Cost ShortTermLeaseCost	10846	usd
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	34929	usd
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	48399	usd
CY2024Q3	us-gaap	Lease Cost LeaseCost	50078	usd
CY2023Q3	us-gaap	Lease Cost LeaseCost	50906	usd
	us-gaap	Lease Cost LeaseCost	152150	usd
	us-gaap	Lease Cost LeaseCost	217895	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	111277	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	145483	usd
CY2024Q3	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	0	usd
CY2023Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	162000	usd
CY2023Q1	idai	Financial Liability Obligation Termination Notice Term FinancialLiabilityObligationTerminationNoticeTerm	P30D

Files In Submission

Name	View Source	Status
0001718939-24-000202-index-headers.html	Edgar Link	pending
0001718939-24-000202-index.html	Edgar Link	pending
0001718939-24-000202.txt	Edgar Link	pending
0001718939-24-000202-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
idai-20240930.htm	Edgar Link	pending
idai-20240930.xsd	Edgar Link	pending
idai-20240930xex311.htm	Edgar Link	pending
idai-20240930xex312.htm	Edgar Link	pending
idai-20240930xex321.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
idai-20240930_cal.xml	Edgar Link	unprocessable
idai-20240930_def.xml	Edgar Link	unprocessable
idai-20240930_pre.xml	Edgar Link	unprocessable
idai-20240930_lab.xml	Edgar Link	unprocessable
idai-20240930_htm.xml	Edgar Link	completed
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$IDAI
T Stamp Inc Stock $idai

2024 Q4 Form 10-Q Financial Statement

#000171893924000202 Filed on November 15, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$IDAI T Stamp Inc Stock $idai

2024 Q4 Form 10-Q Financial Statement

#000171893924000202 Filed on November 15, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$IDAI
T Stamp Inc Stock $idai